Apple, J&J to study if Apple Watch

Qualcomm’s next-gen Snapdragon 865 mobile chip focuses on 5G

Qualcomm teases Snapdragon 865-powered smartphones launching in 2020

 

Some of the Snapdragon 865-powered smartphones launched in 2020 thus far include the Samsung Galaxy S20 series, the iQOO 3 5G and therefore the Realme X50 Pro.

Qualcomm launched its next generation Snapdragon 865 system-on-chip last year in December. Since then, we’ve seen a couple of companies launching smartphones with Snapdragon 865 chipset. a number of the Snapdragon 865-powered smartphones launched in 2020 thus far include the Samsung Galaxy S20 series, the iQOO 3 5G and therefore the Realme X50 Pro.

Now, Qualcomm has teased an inventory of the Snapdragon 865-powered smartphones which will be launched in 2020. The list includes —

— Black Shark 3

— FCNT arrows 5G

— iQOO 3

— Legion Gaming Phone

— Nubia Red Magic 5G

— OPPO Find X2

— Realme X50 Pro

— Redmi K30 Pro
— ROG Phone 3

— Samsung Galaxy S20, S20+, and S20 Ultra

— Sharp AQUOS R5G

— Sony Xperia 1 II

— Vivo APEX 2020 Concept Phone

— Xiaomi Mi 10 and Mi 10 Pro
— ZenFone 7

— ZTE Axon 10s Pro

Qualcomm's next-gen Snapdragon 865 mobile chip focuses on 5G

Some of these phones have already been launched, while others are still in development and can be launched later this year. it’s worth noting that this is often not the whole list of Snapdragon-865 powered smartphones launching in 2020. Qualcomm in its handout said that quite 70 smartphones that are announced or are still in development are going to be powered by the 5G-enabled Snapdragon 865 SoC.

“Additionally, quite 1,750 designs are announced or are in development supported our Snapdragon 8-series mobile platforms,” Qualcomm wrote in its handout .

 

 

Apple, J&J to review if Apple Watch app results in lower stroke risk

 

The joint effort, called “Heartline,” is critical because J&J is one among the world’s largest medical device makers and pharmaceutical companies.
Johnson & Johnson said on Tuesday it might partner with Apple Inc on a study to use an iPhone app and therefore the Apple Watch to review how earlier detection of fibrillation impacts stroke in people aged 65 or older.

Last year, Apple’s Heart Study found that the watch could accurately detect fibrillation , the foremost common sort of irregular heartbeat, consistent with a study that explored the role of wearable devices in identifying potential heart problems. fibrillation increases the danger of stroke quite fivefold, consistent with the American Heart Association.

Jeff Williams, Apple’s chief operating officer, said the initial study proved the Apple Watch can detect fibrillation with a coffee rate of false alarms, which helped Apple gain clearance from the U.S. Food and Drug Administration for a watch app that takes an electrocardiogram, or EKG, measurement. The study with J&J aims to point out if early detection results in better health outcomes.

“We want to follow the science all the thanks to the top , regardless of what the outcomes are, and run this longitudinal study,” Williams told Reuters in an interview. “It’s not something that we’ve to try to to , but it’s the proper thing to try to to .”

The joint effort, called “Heartline,” is critical because J&J is one among the world’s largest medical device makers and pharmaceutical companies.

“What we bring is clinical study capability on a really large scale,” said Paul Stoffels, J&J’s chief scientific officer, who said the study aims to trace 150,000 participants with long-term follow-ups over two years.

The study could also reach a special population than Apple’s original heart study, including 400,000 participants but faced questions from doctors because quite half the people that signed up were under 40, a gaggle already at low risk for fibrillation .

J&J targeted the study at population with a better risk. Paul Burton, vice chairman of medical affairs at the J&J subsidiary running the study, said 70% of patients experiencing the condition are over 65.

“What we’re trying to try to to here is definitively answer that question: If you’re taking wearable technology and couple it with an app, are you able to reduce the danger of a stroke or death?” Burton said.

apple, J&J watch

The J&J study are going to be hospitable the quite 40 million people enrolled in traditional Medicare plans, which cover people aged 65 and older also because the disabled. Study participants are going to be randomly assigned to either use only an iPhone app or use the app in conjunction with a watch capable of taking an EKG.
If patients who enrol are assigned to the arm of the study using the Apple Watch, they’re going to be prompted to accumulate one among the devices, which study officials said the participants can either purchase on their own for private use for $49 or borrow freed from charge for the study.

The latest Apple Watch model starts at asking price of $399. Burton said J&J and Apple were sharing the value of subsidizing the watches. The study can pay participants, who must comply with share their Medicare claims data. Apple and J&J officials said that was key to proving whether the utilization of the app and watch cause reduced stroke risk.

“With tens of many watches on people’s wrists and us delivering this early detection, we’ve an enormous responsibility to form sure that early detection is effective and really helping people with their health within the end of the day ,” Apple’s Williams told Reuters.

Leave a Reply

Your email address will not be published. Required fields are marked *